Research on disease, treatment, and what keeps people well. Coverage runs from lab findings and clinical trials to public health, nutrition, and the health care system.
Epilepsy patients wearing brain electrodes revealed that a breath’s rise and fall lines up with brain wave activity, but only through the nose, not a chest strap, and only in a narrow slice of recordings.
By systematically disabling nearly 12,000 genes across 33.4 million primary human T cells, researchers revealed how genetic networks drastically alter their behavior between resting and activated immune states.
A new philosophical account reframes moral distress in healthcare: not weakness or poor coping, but a byproduct of the perceptual skill that lets clinicians notice ethical problems in the first place.
Toddlers accounted for nearly all of a 3,307 percent jump in unintentional child drug ingestions since 2000, poison center data show, most of it driven by marijuana edibles that resemble candy and pack multiple doses into one package.
Two new lab tools push protein engineering in opposite directions at once: one builds proteins nature never made from an expanded genetic alphabet, the other calculates precisely how to destroy a disease protein already causing harm.
Obese mice ship fat-derived vesicles across the placenta that reprogram fetal liver DNA, switching on glucose production weeks early and setting up glucose intolerance in male offspring by adulthood.
Doctors have long relied on an invasive marrow-sampling procedure to check whether a childhood cancer called rhabdomyosarcoma has advanced. A large international study finds a whole-body imaging scan already in use catches it just as reliably, except in one circumstance.
An old shelved compound called TOFA made obese mice burn about 18% more energy and shed fat while keeping muscle, working the opposite lever to Ozempic. It has never been tested in humans.
Your body makes its own fat. Cells build fatty acids from scratch, all day long. But what if you could switch that off? That is
Beta-2-microglobulin and cystatin C, both already on standard lab menus, tracked future disability in adults over 85 across Japanese and Italian cohorts, pointing to kidney strain and inflammation years before independence slips.
Nearly 250,000 comments poured into FDA dockets on proposed menthol-cigarette and flavored-cigar restrictions. A new analysis finds that most were form letters, many carrying content linked to tobacco-company campaigns.
A national survey of 186,823 US adults finds serious cannabis use disorder rising from 2021 through 2024 in men, women, and most age brackets, while serious alcohol use disorder stayed flat or fell. The sharpest jumps came in middle age and beyond.